| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |